Thursday, July 16 7:30–8:30am
AI-The Good, The Bad, and The Ugly (Navigating the New Reality of AI in Medicine)
Disclosures
The following financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation.
Financial Disclosures
- Peter Lin, MD, CCFP
- Speaker: Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eisai, Eli Lilly, GlaxoSmithKline, Medtronic, Merck, Moderna, Novo Nordisk, Pfizer, Sanofi
Other Disclosures
Pamela Kushner, MD, FAAFP (Reviewer): Speaker and Advisor for AstraZeneca, Boehringer Ingelheim, Corcept, GSK, Haleon, and Novo Nordisk; Speaker for Astellas, Bayer, Janssen, Lilly, and Phathom; Advisor for Abbott and Bausch/SALIX
All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.